Skip to content

Nasya in Dry eye

Efficacy of Anu Taila Nasya in Shushkakshipaka w.s.r. to Dry eye syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050918
Enrollment
25
Registered
2023-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa Health Condition 2: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

CCRAS New Delhi
Lead Sponsor
Govt Ayurved College Bilaspur
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient between 18-70 years of age suffering from Shushkakshipaka (DES) irrespective of sex or religion. 2. Patient having Shushkakshipaka (DES) symptoms â?? feeling of dryness, irritation, foreign body sensation, non specific ocular discomfort and chronically sore eyes, not responding to a variety of drops instilled earlier. 3. Defective blinking such as low blink rate as seen in prolonged computer and mobile phones users. 4. Vitamin A deficiency and other factors affecting ocular surface for example tropical drugs, preservative of contact lens bearers. Ocular surface allergic disease and scarring disorders. 5. Patient ready to give written consent and study till completion only will be selected.

Exclusion criteria

Exclusion criteria: 1. Patient not willing for trial. 2. Allergic by patient report. 3. Pregnancy or lactating mother. 4. Current diagnosis of any of the following ocular conditions- Acute allergic conjunctivitis, infection (bacterial, viral, protozoan or fungal infection of cornea, conjunctiva, lacrimal gland, lacrimal sac or eye lids) 5. Inflammation (retinitis, macular inflammation, choroiditis, uveitis, scleritis, episcleritis and keratitis). 6. History of patient report of ocular herpetic keratitis. 7. Ocular surgery (including cataract surgery) by patient report within six months. 8. Previous LASIK surgery or any other corneal surgery. 9. Use of glaucoma medication or history of filtering surgery for glaucoma. 10. Eye lid abnormalities that affect lid function (blepharospasm, ectropion, entropion, severe trichiasis). 11. Extensive ocular surface scarring or condition that may compromise ocular surface integrity such as Stevens Johnson syndrome, prior chemical burn, recurrent corneal erosions, persistent corneal epithelial defects prior ocular trauma etc.

Design outcomes

Primary

MeasureTime frame
1st, 8th, 15th, 22nd, 29th day Timepoint: 4 Weeks

Secondary

MeasureTime frame
1.Visual symptoms- 2.Conjunctiva- erythematic (bulbar)- 3.Conjunctiva-oedema (bulbar)- 4.Conjunctiva- staining- 5.Cornea- staining- 6.Corneal tear signs- 7.Lid- meibomian glands- 8.Tear film break up time (TBUT)- 9.Schirmerâ??s score- Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Ajay Kumar Pandey

Govt. Ayurved College and Hospital Bilaspur

pandeysavarna@gmail.com8004695496

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026